Fig. 1From: A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed(a) PFS between alectinib and ceritinb treatment groups (b) PFS between the treatment groups in terms of crizotinib treatment failure patternsBack to article page